Aims: To investigate the effect of curcumin on the alterations in renal functional parameters following reversible unilateral ureteric obstruction in the rat. Methods: Wistar rats underwent reversible left ureteric obstruction for 72 h. The group Cm (n = 7) received oral curcumin (200 mg/kg/day), whereas the Vx group (n = 8) had only a vehicle. Results: Ureteric obstruction caused a significant increase in the serum tumour necrosis factor α in both groups. However, the postobstruction level in the Cm group was significantly lower than in the Vx group. In the Vx group, the glomerular filtration rate, renal blood flow, urine volume and urinary sodium excretion in the left obstructed kidney were significantly lower than those in the right kidney, but the fractional excretion of sodium was comparable in the 2 groups. The left kidney in the Cm group behaved similar to that in the Vx group. Moreover, there was no difference in any variable when comparing the right and left kidneys among the groups. Conclusion: Curcumin appears to have no significant protective effect on the haemodynamic or tubular glomerular functions when measured as early as 3 days following reversible ureteric obstruction despite the amelioration in some of the indicators of renal injury.

Keywords:
Renal function, Ureteric obstruction, Curcumin
1.
Klotman PE, Smith SR, Volpp BD, Coffman TM, Yarger WE: Thromboxane synthetase inhibition improves function of hydronephrotic rat kidneys. Am J Physiol 1986;250:F282–F287.
2.
Ozturk H, Ozdemir E, Otcu S, Buyukbayram H, Ihsan Dokucu A: Renal effects on a solitary kidney of specific inhibition of cyclooxygenease-2 after 24 h of complete ureteric obstruction in rats. Urol Res 2002;30:223–226.
3.
Yarger WE, Schocken DD, Harris RH: Obstructive nephropathy in the rat: possible roles for the renin-angiotensin system, prostaglandins, and thromboxanes in postobstructive renal function. J Clin Invest 1980; 65:400–412.
4.
Hammad FT, Wheatley AM, Davis G: Long-term renal effects of unilateral ureteral obstruction and the role of endothelin. Kidney Int 2000;58:242–250.
5.
Salh B, Assi K, Templeman V, Parhar K, Owen D, Gomez-Munoz A, Jacobson K: Curcumin attenuates DNB-induced murine colitis. Am J Physiol Gastrointest Liver Physiol 2003;285:G235–G243.
6.
Nagabhushan M, Bhide SV: Curcumin as an inhibitor of cancer. J Am Coll Nutr 1992;11:192–198.
7.
Mahady GB, Pendland SL, Yun G, Lu ZZ: Turmeric (Curcuma longa) and curcumin inhibit the growth of Helicobacter pylori, a group 1 carcinogen. Anticancer Res 2002;22:4179–4181.
8.
LoTempio MM, Veena MS, Steele HL, Ramamurthy B, Ramalingam TS, Cohen AN, Chakrabarti R, Srivatsan ES, Wang MB: Curcumin suppresses growth of head and neck squamous cell carcinoma. Clin Cancer Res 2005;11:6994–7002.
9.
Jordan WC, Drew CR: Curcumin – a natural herb with anti-HIV activity. J Natl Med Assoc 1996;88:333.
10.
Sharma OP: Antioxidant activity of curcumin and related compounds. Biochem Pharmacol 1976;25:1811–1812.
11.
Bayrak O, Uz E, Bayrak R, Turgut F, Atmaca AF, Sahin S, Yildirim ME, Kaya A, Cimentepe E, Akcay A: Curcumin protects against ischemia/reperfusion injury in rat kidneys. World J Urol 2008;26:285–291.
12.
Srimal RC, Dhawan BN: Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J Pharm Pharmacol 1973;25:447–452.
13.
Ghosh SS, Massey HD, Krieg R, Fazelbhoy ZA, Ghosh S, Sica DA, Fakhry I, Gehr TW: Curcumin ameliorates renal failure in 5/6 nephrectomized rats: role of inflammation. Am J Physiol Renal Physiol 2009;296:F1146–F1157.
14.
Venkatesan N, Punithavathi D, Arumugam V: Curcumin prevents adriamycin nephrotoxicity in rats. Br J Pharmacol 2000;129:231–234.
15.
Aggarwal S, Ichikawa H, Takada Y, Sandur SK, Shishodia S, Aggarwal BB: Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation. Mol Pharmacol 2006;69:195–206.
16.
Hashem RM, Soliman HM, Shaapan SF: Turmeric-based diet can delay apoptosis without modulating NF-kappaB in unilateral ureteral obstruction in rats. J Pharm Pharmacol 2008;60:83–89.
17.
Jones EA, Shahed A, Shoskes DA: Modulation of apoptotic and inflammatory genes by bioflavonoids and angiotensin II inhibition in ureteral obstruction. Urology 2000;56:346–351.
18.
Kuwabara N, Tamada S, Iwai T, Teramoto K, Kaneda N, Yukimura T, Nakatani T, Miura K: Attenuation of renal fibrosis by curcumin in rat obstructive nephropathy. Urology 2006;67:440–446.
19.
Schreiner GF, Harris KP, Purkerson ML, Klahr S: Immunological aspects of acute ureteral obstruction: immune cell infiltrate in the kidney. Kidney Int 1988;34:487–493.
20.
Harris KP, Schreiner GF, Klahr S: Effect of leukocyte depletion on the function of the postobstructed kidney in the rat. Kidney Int 1989;36:210–215.
21.
Misseri R, Meldrum DR, Dinarello CA, Dagher P, Hile KL, Rink RC, Meldrum KK: TNF-alpha mediates obstruction-induced renal tubular cell apoptosis and proapoptotic signaling. Am J Physiol Renal Physiol 2005;288:F406–F411.
22.
Meldrum KK, Misseri R, Metcalfe P, Dinarello CA, Hile KL, Meldrum DR: TNF-alpha neutralization ameliorates obstruction-induced renal fibrosis and dysfunction. Am J Physiol Regul Integr Comp Physiol 2007;292:R1456–R1464.
23.
Guo G, Morrissey J, McCracken R, Tolley T, Klahr S: Role of TNFR1 and TNFR2 receptors in tubulointerstitial fibrosis of obstructive nephropathy. Am J Physiol 1999;277:F766–F772.
24.
Kim KH, Lee ES, Cha SH, Park JH, Park JS, Chang YC, Park KK: Transcriptional regulation of NF-kappaB by ring type decoy oligodeoxynucleotide in an animal model of nephropathy. Exp Mol Pathol 2009;86:114–120.
25.
Kaneto H, Morrissey J, McCracken R, Reyes A, Ishidoya S, Klahr S: The expression of mRNA for tumor necrosis factor-a increases in the obstructed kidney of rats soon after unilateral ureteral ligation. Nephrologie 1996;2:161–166.
26.
Kelly KJ: Distant effects of experimental renal ischemia/reperfusion injury. J Am Soc Nephrol 2003;14:1549–1558.
27.
Ito K, Chen J, El Chaar M, Stern JM, Seshan SV, Khodadadian JJ, Richardson I, Hyman MJ, Vaughan ED Jr, Poppas DP, Felsen D: Renal damage progresses despite improvement of renal function after relief of unilateral ureteral obstruction in adult rats. Am J Physiol Renal Physiol 2004;287:F1283–F1293.
28.
Rosen S, Peters CA, Chevalier RL, Huang WY: The kidney in congenital ureteropelvic junction obstruction: a spectrum from normal to nephrectomy. J Urol 2008;179:1257–1263.
29.
Bander SJ, Buerkert JE, Martin D, Klahr S: Long-term effects of 24-hour unilateral ureteral obstruction on renal function in the rat. Kidney Int 1985;28:614–620.
30.
Gottschalk CW, Mylle M: Micropuncture study of pressures in proximal tubules and peritubular capillaries of the rat kidney and their relation to ureteral and renal venous pressures. Am J Physiol 1956;185:430–439.
31.
Safirstein R, Wright FS: Renal vessel and tubule pressures during and after obstruction of one or both ureters. Fed Proc 1975;34:393.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.